Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 HKD | -4.41% | +1.56% | -67.17% |
Business Summary
Number of employees: 100
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Products
100.0
%
| 92 | 100.0 % | 114 | 100.0 % | +23.78% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
54.3
%
| 37 | 39.9 % | 62 | 54.3 % | +68.60% |
Other Regions
45.7
%
| 55 | 60.1 % | 52 | 45.7 % | -5.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 19-04-01 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Minnie Ke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qian Ma
CMP | Compliance Officer | - | 21-06-20 |
Pauline Li
COO | Chief Operating Officer | - | 22-05-07 |
Isabella Zhao
IRC | Investor Relations Contact | - | - |
Zhang Wei
PRN | Corporate Officer/Principal | - | - |
Hu Tianxin
PRN | Corporate Officer/Principal | - | - |
Chris Chen
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 22-07-04 |
James Geraghty
BRD | Director/Board Member | 69 | 18-07-17 |
Peng Kuan Chan
BRD | Director/Board Member | 60 | 21-06-10 |
Lan Hu
BRD | Director/Board Member | 55 | 22-02-15 |
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Richard Gregory
BRD | Director/Board Member | 66 | 20-04-20 |
53 | - | ||
Kan Chen
BRD | Director/Board Member | 42 | 20-12-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 424,838,320 | 382,285,184 ( 89.98 %) | 0 | 89.98 % |
Company contact information
CANbridge Pharmaceuticals Inc.
Suite 301, 3F, TImeloit No. 17 RongChuang Road
, Beijing
+86 10 6478 0016
http://www.canbridgepharma.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-67.17% | 18.49M | |
+18.49% | 78.7B | |
+14.09% | 9.26B | |
-15.14% | 4.92B | |
+45.17% | 4.66B | |
+15.70% | 4.27B | |
+16.71% | 2.44B | |
-26.13% | 2.22B | |
+15.73% | 2.15B | |
-40.52% | 1.89B |
- Stock Market
- Equities
- 1228 Stock
- Company CANbridge Pharmaceuticals Inc.